Anti-PON2 monoclonal antibody, clone FQS26306

Active optical networks (AONs) have been one of the most deployed fiber access solutions in Europe. However, with the increasing traffic demand, the capacity of the existing AONs is becoming insufficient. For the legacy AONs, there are two major variants of architectures, namely, point-to-point and active star. Considering the different characteristics of these two AON architectures, this paper proposes and analyzes several migration paths toward next-generation optical access (NGOA) networks offering a minimum 300 Mbit/s sustainable bit rate and 1 Gbit/s peak bit rate to every end customer. Furthermore, this paper provides detailed descriptions of the network cost modeling and the processes for AON migration. The total cost of ownership (TCO) is evaluated for the proposed migration paths, taking into account different migration starting times, customer penetration, node consolidation, and business roles in the fiber access networks. The migration from AON to NGOA can be economically feasible. The results indicate that a network provider plays a key business role and is responsible for the major part of the TCO for AON migration. Moreover, performing node consolidation during AON migration can be beneficial from a cost point of view, especially in rural areas.

Introduction: Paraoxonases are a group of different forms enzymes that consist of three non-similar isoforms, PON1, PON2 and PON3, which are located near to each other on the long arm of chromosome7. This study aims to investigate the association of a Q192R polymorphism of PON1 gene and statin response in patients with ischemic heart disease with dyslipidemia. Methods: The studied population included three hundred patients with coronary artery disease with dyslipidemia who were prescribed statins. Total lipid profile was measured in these patients both before and after approximately 6 months of treatment. Q192R polymorphism of PON1 gene was assessed by real-time PCR. Results: There were no significant differences in baseline lipid levels according to different genotypes in all studied casesof Q192R (rs662) polymorphism. HDL-C goals were attained less often in patients with RR homozygosity than in Q allele carriers. Analysis by univariate logistic regression confirmed that QQ/QR carriers had an increased chance of attaining HDL-C goals. Conclusion: This study shows that the Q192R polymorphism of PON1gene has important role in interindividual variety in accomplishment of HDL-C goals in response to statins.